{"id":"NCT01341639","sponsor":"MCM Vaccines B.V.","briefTitle":"Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)","officialTitle":"A Phase III Randomized, Double-Blind, Active-Comparator Controlled Clinical Trial to Study the Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4, and 12 Months (V419-007-03)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-05-26","primaryCompletion":"2013-03-13","completion":"2013-03-13","firstPosted":"2011-04-26","resultsPosted":"2019-04-10","lastUpdate":"2019-04-30"},"enrollment":1250,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Bacterial Infections","Virus Diseases"],"interventions":[{"type":"BIOLOGICAL","name":"V419","otherNames":[]},{"type":"BIOLOGICAL","name":"INFANRIX™ hexa","otherNames":[]},{"type":"BIOLOGICAL","name":"RotaTeq","otherNames":[]},{"type":"BIOLOGICAL","name":"Prevenar 13","otherNames":[]},{"type":"BIOLOGICAL","name":"ProQuad™","otherNames":[]}],"arms":[{"label":"PR5I","type":"EXPERIMENTAL"},{"label":"INFANRIX™ hexa","type":"ACTIVE_COMPARATOR"}],"summary":"This study will determine whether participants who receive the vaccine V419 at 2, 3, 4, and 12 months of age have an acceptable immune response to the vaccine. The study will also determine whether the immune response to V419 is similar to that of participants who receive a licensed vaccine control.","primaryOutcome":{"measure":"Percentage of Participants Vaccinated With PR5I With Acceptable Antibody (Ab) Response to Haemophilus Influenzae Type b, Diphtheria, Tetanus, and Poliovirus Types 1, 2 & 3, at 5 Months","timeFrame":"One month after post-dose 3 of PRI5 (5 months old)","effectByArm":[{"arm":"PR5I","deltaMin":98.36,"sd":null}],"pValues":[]},"eligibility":{"minAge":"46 Days","sex":"ALL","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":14},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["27846055"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":23,"n":610},"commonTop":["Irritability","Crying","Somnolence","Pyrexia","Injection site pain"]}}